Rx-To-OTC Switch Flips On With June Public Forum, July NDAC Meeting

The suitability of specific Rx drug classes - such as antihypertensive agents, osteoporosis treatments and oral contraceptives - for OTC use will be examined by FDA at a June 28-29 meeting in Gaithersburg, Md.

More from Archive

More from Pink Sheet